Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia.

Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.

Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.

Bone marrow effects of anagrelide therapy in patients with myelofibrosis with myeloid metaplasia.

Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995.

Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases.

Clinical correlations of immunophenotypic variations and the presence of trisomy 12 in B-cell chronic lymphocytic leukemia.

Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of actin, efficacy, toxicity, current indications.